Clinical and Experimental Metastasis

Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1..  35:77-86. 2018

Perspective on the interpretation of research and translation to clinical care with therapy-associated metastatic breast cancer progression as an example..  34:443-447. 2017

Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer..  34:229-239. 2017

MTBP inhibits migration and metastasis of hepatocellular carcinoma..  32:301-311. 2015

Diet modulation is an effective complementary agent in preventing and treating breast cancer lung metastasis..  31:625-638. 2014

Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas..  31:497-510. 2014

FAK inhibition decreases cell invasion, migration and metastasis in MYCN amplified neuroblastoma..  30:555-568. 2013

L1CAM stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor..  30:507-520. 2013

NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma..  30:25-36. 2013

Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis..  29:315-325. 2012

CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell-like properties and correlate to survival..  28:400-406. 2012

Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines..  28:437-449. 2011

KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model..  27:591-600. 2010

BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter..  26:229-237. 2009

Dietary stearate reduces human breast cancer metastasis burden in athymic nude mice..  26:415-424. 2009

Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma..  26:739-749. 2009

Multi-faceted role of HSP40 in cancer..  26:559-567. 2009

Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model..  26:89-96. 2009

Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution..  26:527-533. 2009

Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer..  25:753-763. 2008

Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs..  25:893-901. 2008

Syndecan-1: a dynamic regulator of the myeloma microenvironment..  25:149-159. 2008

Breast cancer metastasis to bone: evaluation of bioluminescent imaging and microSPECT/CT for detecting bone metastasis in immunodeficient mice..  24:389-401. 2007

Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression..  24:551-565. 2007

Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435..  23:123-133. 2006

A novel assay for the quantification of invasion from raft cultures of lung carcinomas..  21:1-6. 2004

A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis..  21:119-128. 2004

Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells..  21:149-157. 2004

Breast cancer metastasis suppressor 1: update..  20:45-50. 2003

Clinical & Experimental Metastasis: Introduction.  20:187. 2003

Clinical and Experimental Metastasis: Introduction.  20:1-2. 2003

Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice..  20:321-325. 2003

KISS1 metastasis suppression and emergent pathways..  20:11-18. 2003

MDA-MB-435 human breast carcinoma metastasis to bone..  20:327-334. 2003

The skeleton as a unique environment for breast cancer cells..  20:275-284. 2003

B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy..  19:369-376. 2002

Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells..  19:95-105. 2002

Analysis of mechanisms underlying BRMS1 suppression of metastasis..  18:683-693. 2000

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells..  18:391-400. 2000

The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines..  18:519-525. 2000

Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate..  17:601-607. 1999

Calcitriol enhancement of TPA-induced tumorigenic transformation is mediated through vitamin D receptor-dependent and -independent pathways..  15:580-592. 1997

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23)..  15:259-265. 1997

Technical considerations for studying cancer metastasis in vivo..  15:272-306. 1997

Epidermal growth factor modulates cell attachment to hyaluronic acid by the cell surface glycoprotein CD44..  14:268-276. 1996

In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals..  13:407-419. 1995

U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis..  11:201-212. 1993

Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas..  8:533-551. 1990

A novel method for selection of invasive tumor cells: derivation and characterization of highly metastatic K1735 melanoma cell lines based on in vitro and in vivo invasive capacity..  6:301-318. 1988

Implications of tumor progression on clinical oncology..  3:151-188. 1985

Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials..  2:271-286. 1984

Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties..  2:333-355. 1984

Multiple phenotypic divergence of mammary adenocarcinoma cell clones. II. Sensitivity to radiation, hyperthermia and FUdR..  2:357-371. 1984

Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro..  1:317-325. 1983